• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What are Clinical Trials?
    • Become a Clinical Trial Volunteer
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Sanguine expands services into the clinical space

Sanguine expands services into the clinical space

June 4, 2015
CenterWatch Staff

Sanguine, a Los Angeles, Calif.-based technology company providing services to the personalized medicine and biomedical research market, is expanding its services to improve clinical trial efficiency through enhanced patient recruitment, retention and trial procedures. Sanguine, which primarily operated in the preclinical space until now, will be fulfilling needs in later stage clinical development through a combination of smart technology and adaptable mobile health force.

“Currently, the clinical trial process is slow and inefficient. Trials take 30%-40% longer than expected due to poor recruitment, 15%-40% of patients drop out before they finish and trial procedures are becoming increasingly complex,” said Brian Neman, CEO and co-founder of Sanguine. “There is a huge need in the market to solve these issues and make the clinical trial process faster and more robust. At Sanguine, we are committed to advancing biomedical research by providing a comprehensive solution that spans the entire clinical development process.”

Sanguine offers a personalized approach to patient visits and sample collection. Through the Sangre Dashboard, a portal used to track patient progress and submit requests for at home visits, sites can better monitor activities and appointments. After a patient schedules an appointment through the Sangre Dashboard, a local phlebotomist or nurse from Sanguine’s protocol-trained Mobile Health Force is alerted on Sangre, Sanguine’s proprietary mobile application, and dispatched to the patient’s home to perform trial procedures.

After samples and data are processed and submitted, the site is notified of completion via the Sangre Dashboard. Sanguine’s Mobile Health Force spans across 42 cities in the U.S., Canada, Italy and the U.K. The combination of Sanguine’s unique technology and global team of health professionals results in wider patient access, improved retention and compliance rates, an earlier last site last visit (LSLV) as well as reduced per site and per patient cost.

“By expanding our focus to include the clinical space, we will have the opportunity to work with a much larger research population and make a greater impact on medical research,” said Carlyn Crisostomo, chief operating officer of Sanguine. “Our goal is to create a more efficient clinical trial process for both researchers and patients by leveraging technologies like our Sangre Dashboard and Sangre Mobile Application.”

With over 200 unique protocols completed and partnerships with top pharmas, Sanguine is committed to creating the next generation of treatment and diagnostics for a multitude of diseases. Sanguine is currently working on studies with an emphasis on autoimmune and rare conditions.

    Upcoming Events

    • 05Dec

      Thriving in Clinical Research – Overcoming Common Challenges as a Site: Part 3 – Site Resourcing

    • 14Apr

      MAGI 2024: The Clinical Research Conference

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Jonathan Seltzer

      Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials

    • Quality_Compass-360x240.png

      Ask the Experts: Applying Quality by Design to Protocols

    • Obesity Treatment Patient

      Clinical Trials Need Greater Representation of Obese Patients, Experts Say

    • Modernize-360x240.png

      FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing